This secondary analysis of a randomized clinical trial examines whether longitudinal increases in high-sensitivity C-reactive protein levels during 16 weeks after an acute coronary syndrome are associated with increased risk of a major adverse cardiac event, cardiovascular death, and all-cause death.
This study assesses in vivo the coronary atherosclerotic phenotype as well as the prevalence and characteristics of healed coronary plaques by optical coherence tomography imaging in patients with recurrent acute coronary syndromes compared with patients with long-term clinical stability.
This cohort study examines survival following treatment with drug-coated devices compared with non–drug-coated devices for Centers for Medicare and Medicaid Services beneficiaries who were admitted for femoropopliteal artery revascularization.
This analysis of data from the 2016 Global Burden of Disease Study examines the national and province-level mortality, prevalence, and disability-adjusted life-years associated with cardiovascular disease in China from 1990 to 2016.
This cohort study assesses cardiovascular disease risks, incidence, hospitalization, and mortality among patients with end-stage renal disease aged 1 to 29 years to determine whether patients aged 22 to 29 years have risks that differ from those of younger patients.
This community surveillance study uses data from communities in Maryland, Minnesota, Mississippi, and North Carolina to explore the association of monthly influenza-like illness activity with myocardial infarction and heart failure hospitalizations.
This post hoc analysis of data from randomized clinical trials investigates the clinical value of fractional flow reserve in patients who have undergone percutaneous coronary intervention.
This study evaluates the challenges of using the Social Security Administration Death Master File mortality data, particularly for analyzing mortality trends among patients with atherosclerotic cardiovascular disease.
This Viewpoint describes a novel type of mitral regurgitation and describes its treatment with a device called the MitraClip.
This first-person narrative includes the perspectives of a cardiology fellow, an attending physician, and a patient awaiting a heart-liver transplant on the experience of waiting for organs to become available.
This Viewpoint discusses 2 randomized clinical trials of the MitraClip, a novel treatment for secondary mitral regurgitation.
This narrative review discusses the evidence for clonal hematopoiesis as a physiological factor connecting cancer and cardiovascular disease.
A man in his early 40s is admitted with acute chest pain and high serum concentrations of IgG4. What would you do next?
Create a personal account or sign in to: